Impax takes on detailing for Pfizer's Lyrica; GSK slates N.J. toothpaste plant for closure;

  @FiercePharma: Overhauling U.S. pharma biz, Novartis lays off 250. Report | Follow @FiercePharma

> Impax Pharmaceuticals says it will start co-promoting Pfizer's Lyrica to neurologists as an adjunct therapy for seizures, but will drop detailing on the antidepressant Pristiq. Release | Report

> GlaxoSmithKline plans to close its toothpaste factory in Clifton, N.J., by 2012, ending more than half a century in the Passaic County city. Report

> Danish pharma Lundbeck says it won one court case regarding generic rivals to its Cipralex antidepressant, but lost another. Report

> Generic drugmaker Akorn got the FDA's nod for its generic version of the painkiller Dilaudid-HP. Report

> Alexion Pharmaceuticals won Japanese approval to market its drug Soliris for paroxysmal nocturnal hemoglobinuria. Report

> Solvay Pharma India had about 397,050 shares, or 7.9 percent of its equity, change hands in a single block deal on the Bombay Stock Exchange. Report

Biotech News

 @FierceBiotech: Third Rock raising $400M venture fund for biotech "game-changers." Report | Follow @FierceBiotech

 @JohnCFierce: Judging 3 categories for the World Vaccines Congress awards. I have to say the level of innovation in vaccines today is extraordinary. | Follow @JohnCFierce

> Genocea teams with military on malaria vax research. Story

> Survey: Quebec's biotech industry in peril. Report

> Venture capital dips in Q1, but biotech still leads the pack. Story

> Oracle buys Phase Forward for $685 million. Report

> Report: U.S. cancer trials are in a state of crisis. Report

And Finally... Pfizer was voted as the best employer in Czech Republic in a ranking organized by consulting firm Hewitt Associates. Report